CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study) Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
|<<... 5 6 7 8 9 10 11 ...>>|

Consensus2019 Dec 27[Online ahead of print]

JOURNAL：Catheter Cardiovasc Interv. Article Link

SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography and Intervention

AR Shroff, Rajiv Gulati, DE Drachman et al. Keywords: transradial angiography; ultrasound; ulnar artery access; non-invasive testing of collateral flow; radial artery occlusion prevention

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top